Investors

Ceretas is a clinical-stage medtech company developing a portable, non-invasive therapeutic ultrasound platform to treat Alzheimer’s disease and other neurodegenerative conditions. Here you will find our ASX announcements, investor presentations, corporate governance documents, and financial disclosures.

ASX Announcements

View all Ceretas (CTS) announcements on the Australian Securities Exchange (ASX). 

ASX announcements

Share Price




Corporate Governance

Ceretas is committed to strong corporate governance and compliance with the ASX Corporate Governance Principles.

Governance Documents

Board Charter

Remuneration and Nomination Committee Charter

Audit and Risk Management Committee Charter

Disclosure and Communication Policy

Diversity Policy

Anti-Bribery and Corruption Policy

Whistleblower Policy

Code of Conduct

Risk Management Policy

Securities Trading Policy

Corporate Governance Statement

Share Registry

Shareholders should contact the share registry directly to update shareholder details, manage holdings, or access registry services.

Automic Group
1300 288 644 (within Australia)
+61 2 9698 5414 (outside Australia)
hello@automicgroup.com.au
www.automicgroup.com.au